Table 2.
Models | Training cohort | Validation cohort | ||||||
---|---|---|---|---|---|---|---|---|
AUC (95% CI) | ACC | SPE | SEN | AUC (95% CI) | ACC | SPE | SEN | |
Radiomic nomogram | 0.745 (0.696–0.795) | 0.716 | 0.659 | 0.765 | 0.758 (0.685–0.831) | 0.673 | 0.514 | 0.793 |
Combined radiomic signature | 0.715 (0.663–0.767) | 0.671 | 0.757 | 0.598 | 0.714 (0.636–0.792) | 0.642 | 0.743 | 0.565 |
Tumor-based model | 0.714 (0.662–0.766) | 0.663 | 0.827 | 0.525 | 0.715 (0.637–0.792) | 0.630 | 0.800 | 0.500 |
Peripheral ring-based model | 0.660 (0.605–0.714) | 0.629 | 0.740 | 0.534 | 0.659 (0.576–0.741) | 0.617 | 0.729 | 0.533 |
Clinical model 1 (CTT + CTN) | 0.622 (0.566–0.678) | 0.589 | 0.694 | 0.500 | 0.586 (0.498–0.674) | 0.574 | 0.586 | 0.565 |
Clinical model 2 (age + CTT + CTN) | 0.663 (0.608–0.718) | 0.623 | 0.711 | 0.549 | 0.605 (0.518–0.692) | 0.574 | 0.586 | 0.565 |
NOTE. Abbreviations: AUC Area under the curve, CI Confidence interval, ACC Accuracy, SPE Specificity, SEN Sensitivity, CTT CT T stage, CTN CT N stage